Therefore, postnatal epigenetic modifications of VDR-mediated signaling and vitamin D metabolism may serve as a second hit and contribute to the clinical variability and severity of TSC, including the development of tumors, abnormal synaptic plasticity, and epilepsy. The gene discussed is VDR; the disease is tuberous sclerosis.